Price change (24h):
1.27%
High (24h):
$533.55
Low (24h):
$524.11
Volume (24h):
$57.41K
Market Cap:
$4.03K
All Time High:
0.46% $533.55
Jul 6, 2026
All Time Low:
28% $415.19
May 5, 2026
0.00 %(1Y)
$531.23
Price change (24h):
1.27%
High (24h):
$533.55
Low (24h):
$524.11
Volume (24h):
$57.41K
Market Cap:
$4.03K
All Time High:
0.46% $533.55
Jul 6, 2026
All Time Low:
28% $415.19
May 5, 2026
Vertex Pharmaceuticals Tokenized Stock (Ondo) (VRTXon) is a cryptocurrency that tokenizes exposure to the biopharmaceutical company Vertex Pharmaceuticals Incorporated. It exists as a regulated on-chain wrapper, merging traditional equity performance with programmable ledger settlement.
The asset strips away the jurisdictional friction that locks countless global investors out of US equity markets. Non-US retail and institutional actors gain economic exposure mirroring outright stock ownership—including automatic dividend reinvestment—without requiring a US brokerage account or enduring the latency of cross-border settlement. Token minting and redemption flow through Ondo’s infrastructure 24 hours a day, five days a week, always anchored to the liquidity of the underlying NYSE-listed security.
VRTXon operates on the Solana network. A simultaneous presence on Ethereum and BNB Smart Chain broadens its accessibility, with each deployment calibrating to the native token standards of its host chain.
On Solana, the asset conforms to the SPL token specification, leveraging Solana’s sub-second block times for near-instant settlement. The Ethereum version adheres to the ERC-20 standard, while the BNB Chain iteration follows BEP-20. This multi-standard architecture ensures compatibility with major non-custodial wallets, institutional custodians, and DeFi protocols across three of the most liquid smart contract ecosystems.
The token emerges from the Ondo Global Markets framework, a specialized suite built by Ondo Finance to deliver tokenized US equities and ETFs on-chain. Rather than a grassroots crypto project, VRTXon originates from a compliance-first structure where regulated entities custody the equity shares and enforce whitelisting; the token acts as a cryptographic representation of that custodial claim. Its genesis ties to the broader real-world asset movement gaining traction as DeFi protocols seek traditional yield sources.
The long-term objective recoils from speculative token dynamics and instead pushes for a functional parallel market architecture. By reconciling on-chain programmability with off-chain stock liquidity, the aim is to collapse the barriers between regions so that capital formation and risk management no longer depend on one’s physical location or banking relationships.
Each VRTXon unit tracks the total return of Vertex Pharmaceuticals shares, embedding price changes and any dividends into its net asset value. Minting requires the injection of fiat-equivalent stablecoins through approved onramps, which triggers the issuance of new tokens by the Ondo protocol; redemptions burn tokens and release the pegged value. The mechanism relies on a dynamic supply that expands or contracts in lockstep with verified capital flows, not a fixed emission schedule.
An institutional trader in Southeast Asia whitelisted for Ondo’s services can mint VRTXon during Asian market hours, effectively purchasing Vertex risk while the New York Stock Exchange is closed. A European DeFi fund might hold the token inside a non-custodial wallet as a compliant bridge to US biotech exposure, bypassing the time and cost of traditional cross-border brokerage. Because the asset trades on decentralized secondary markets, arbitrageurs can exploit temporary price dislocations against the underlying equity’s fair value during pre-market or after-hours windows.
VRTXon has a total supply of 1.03420946 tokens. Currently, 1.03420946 are in circulation. With a market capitalization of $444.68, Vertex Pharmaceuticals Tokenized Stock (Ondo) ranks #12,353 among all cryptocurrencies.
| Date | Open | Close | High | Low |
|---|---|---|---|---|
| 06/07/2026 | $527.97 | $531.65 | $532.75 | $524.11 |
| 05/07/2026 | $524.40 | $524.71 | $528.23 | $524.13 |
| 04/07/2026 | $524.53 | $524.40 | $528.26 | $524.10 |
| 03/07/2026 | $525.57 | $524.37 | $528.19 | $523.99 |
| 02/07/2026 | $496.38 | $522.81 | $524.94 | $491.94 |
| 01/07/2026 | $496.43 | $496.77 | $501.07 | $485.60 |
| 30/06/2026 | $496.62 | $496.20 | $498.98 | $491.61 |
| 29/06/2026 | $491.47 | $496.37 | $497.40 | $486.26 |
AI trades 24/7 automatically Catch every opportunity
Zero-emotion algorithm Disciplined strategy
Passive income Set & forget automation
20,000+
traders trusted Stoic AI
$200M+
in cumulative assets under management since inception
2015
year of company foundation
Disclaimer:
This website is operated by Cindicator Ltd. (“Cindicator”), a Gibraltar private company. You are solely responsible for compliance with all laws that may apply to you and your use of Cindicator products. Cryptocurrencies and blockchain technologies have been the subject of scrutiny by regulatory bodies worldwide. With respect to your use of Cindicator products, Cindicator makes no representations regarding the applicability or compliance of its products with any laws or regulations, including, without limitation, those related to trading, options, derivatives, or securities. You also assume all legal, economic, and other risks related to your use of Cindicator products, including legal uncertainty, market volatility, and information security risks, among others. Trading in cryptocurrencies and digital assets is highly speculative, and the value of investments can fluctuate dramatically. You may lose a substantial portion or even all of your invested capital, and such trading may not be suitable for everyone. If you are unsure about these risks or your ability to bear potential losses, you should consult with an independent financial advisor before using Cindicator products. Depending on your jurisdiction, access to or use of Cindicator products may be subject to certain legal restrictions or prohibitions. You agree that it is solely your responsibility to determine and comply with any laws and regulations applicable to your use of Cindicator products, and that Cindicator is not responsible for informing you of such requirements.
Cindicator reserves the right to restrict or refuse access to its products for citizens or residents of certain jurisdictions, including those subject to international sanctions or other legal restrictions. All materials provided on this website (including any graphical materials regarding trading strategy performance or P&L) are presented solely for marketing and informational purposes. They do not guarantee any future profits and should not be construed as financial, investment, legal, or other professional advice. Cindicator is not a registered broker-dealer, investment adviser, or regulated financial institution, and the information and services provided do not constitute personal investment advice or a recommendation or offer to buy or sell any securities, cryptocurrencies, or other financial instruments. The information provided herein is summary in nature, does not purport to be complete, and is provided “as is” without any warranty as to its accuracy or completeness. All content may be updated or changed at any time without notice. Past performance is not indicative of future results. To the maximum extent permitted by law, Cindicator (including its directors, officers, and affiliates) shall not be liable for any loss or damage (direct, indirect, special, consequential, or incidental) arising from your use of Cindicator products, this website, or any information contained herein. Please read our Terms of Use for further details. If you do not agree with these terms, please close this site.